These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35263638)

  • 1. SARS-CoV-2 reinfection prevents acute respiratory disease in Syrian hamsters but not replication in the upper respiratory tract.
    Hansen F; Meade-White K; Clancy C; Rosenke R; Okumura A; Hawman DW; Feldmann F; Kaza B; Jarvis MA; Rosenke K; Feldmann H
    Cell Rep; 2022 Mar; 38(11):110515. PubMed ID: 35263638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Reinfection with SARS-CoV-2 Omicron Variants in Previously Infected Hamsters.
    Shiwa-Sudo N; Sakai Y; Iwata-Yoshikawa N; Watanabe S; Yamada S; Kuroda Y; Yamamoto T; Shirakura M; Fujisaki S; Miyazaki K; Miura H; Nagata S; Fukushi S; Maeda K; Hasegawa H; Suzuki T; Nagata N
    J Virol; 2023 Jan; 97(1):e0136622. PubMed ID: 36633406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prior aerosol infection with lineage A SARS-CoV-2 variant protects hamsters from disease, but not reinfection with B.1.351 SARS-CoV-2 variant.
    Yinda CK; Port JR; Bushmaker T; Fischer RJ; Schulz JE; Holbrook MG; Shaia C; de Wit E; van Doremalen N; Munster VJ
    Emerg Microbes Infect; 2021 Dec; 10(1):1284-1292. PubMed ID: 34120579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasal Mucosa Exploited by SARS-CoV-2 for Replicating and Shedding during Reinfection.
    Li H; Zhao X; Li J; Zheng H; Zhao Y; Yang J; Zhou J; Yang F; Chen Y; Zuo Y; Lai Q; Long H; Li Y; Jin W; Shi H; Liu L
    Viruses; 2022 Jul; 14(8):. PubMed ID: 35893674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 Variant Pathogenesis Following Primary Infection and Reinfection in Syrian Hamsters.
    Plunkard J; Mulka K; Zhou R; Tarwater P; Zhong W; Lowman M; Wong A; Pekosz A; Villano J
    mBio; 2023 Apr; 14(2):e0007823. PubMed ID: 37036339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective Immunity of the Primary SARS-CoV-2 Infection Reduces Disease Severity Post Re-Infection with Delta Variants in Syrian Hamsters.
    Mohandas S; Yadav PD; Shete A; Nyayanit D; Jain R; Sapkal G; Mote C
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35337002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term immunity in convalescent Syrian hamsters provides protection against new-variant SARS-CoV-2 infection of the lower but not upper respiratory tract.
    Stauft CB; Selvaraj P; Lien CZ; Starost MF; Wang TT
    J Med Virol; 2022 Jun; 94(6):2833-2836. PubMed ID: 35128693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Assessment of Severe Acute Respiratory Syndrome Coronavirus 2 Variants in the Ferret Model.
    Pulit-Penaloza JA; Belser JA; Sun X; Pappas C; Brock N; Kieran TJ; Ritter JM; Seixas JN; Jones J; Basu Thakur P; Pusch E; Wang L; Tumpey TM; Wentworth DE; Zhou B; Maines TR
    mBio; 2022 Oct; 13(5):e0242122. PubMed ID: 36135377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune durability and protection against SARS-CoV-2 re-infection in Syrian hamsters.
    Field CJ; Heinly TA; Patel DR; Sim DG; Luley E; Gupta SL; Vanderford TH; Wrammert J; Sutton TC
    Emerg Microbes Infect; 2022 Dec; 11(1):1103-1114. PubMed ID: 35333692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against reinfection with D614- or G614-SARS-CoV-2 isolates in golden Syrian hamster.
    Brustolin M; Rodon J; Rodríguez de la Concepción ML; Ávila-Nieto C; Cantero G; Pérez M; Te N; Noguera-Julián M; Guallar V; Valencia A; Roca N; Izquierdo-Useros N; Blanco J; Clotet B; Bensaid A; Carrillo J; Vergara-Alert J; Segalés J
    Emerg Microbes Infect; 2021 Dec; 10(1):797-809. PubMed ID: 33825619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prior infection with SARS-CoV-2 WA1/2020 partially protects rhesus macaques against reinfection with B.1.1.7 and B.1.351 variants.
    Chandrashekar A; Liu J; Yu J; McMahan K; Tostanoski LH; Jacob-Dolan C; Mercado NB; Anioke T; Chang A; Gardner S; Giffin VM; Hope DL; Nampanya F; Patel S; Sanborn O; Sellers D; Wan H; Martinot AJ; Baczenas JJ; O'Connor SL; Pessaint L; Valentin D; Espina B; Wattay L; Ferrari MG; Brown R; Cook A; Bueno-Wilkerson D; Teow E; Andersen H; Lewis MG; Barouch DH
    Sci Transl Med; 2021 Nov; 13(618):eabj2641. PubMed ID: 34546094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenicity of SARS-CoV-2 Omicron (R346K) variant in Syrian hamsters and its cross-neutralization with different variants of concern.
    Mohandas S; Yadav PD; Sapkal G; Shete AM; Deshpande G; Nyayanit DA; Patil D; Kadam M; Kumar A; Mote C; Jain R
    EBioMedicine; 2022 May; 79():103997. PubMed ID: 35405385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 B.1.1.7 Infection of Syrian Hamster Does Not Cause More Severe Disease, and Naturally Acquired Immunity Confers Protection.
    Nuñez IA; Lien CZ; Selvaraj P; Stauft CB; Liu S; Starost MF; Wang TT
    mSphere; 2021 Jun; 6(3):e0050721. PubMed ID: 34133199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenic and transcriptomic differences of emerging SARS-CoV-2 variants in the Syrian golden hamster model.
    O'Donnell KL; Pinski AN; Clancy CS; Gourdine T; Shifflett K; Fletcher P; Messaoudi I; Marzi A
    EBioMedicine; 2021 Nov; 73():103675. PubMed ID: 34758415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunity elicited by natural infection or Ad26.COV2.S vaccination protects hamsters against SARS-CoV-2 variants of concern.
    Tostanoski LH; Yu J; Mercado NB; McMahan K; Jacob-Dolan C; Martinot AJ; Piedra-Mora C; Anioke T; Chang A; Giffin VM; Hope DL; Wan H; Bondzie EA; Mahrokhian SH; Wrijil LM; Bauer K; Pessaint L; Porto M; Piegols J; Faudree A; Spence B; Kar S; Amanat F; Krammer F; Andersen H; Lewis MG; Wegmann F; Zahn R; Schuitemaker H; Barouch DH
    Sci Transl Med; 2021 Nov; 13(618):eabj3789. PubMed ID: 34705477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern.
    Hawman DW; Meade-White K; Archer J; Leventhal SS; Wilson D; Shaia C; Randall S; Khandhar AP; Krieger K; Hsiang TY; Gale M; Berglund P; Fuller DH; Feldmann H; Erasmus JH
    Elife; 2022 Feb; 11():. PubMed ID: 35191378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-administration of Favipiravir and the Remdesivir Metabolite GS-441524 Effectively Reduces SARS-CoV-2 Replication in the Lungs of the Syrian Hamster Model.
    Chiba S; Kiso M; Nakajima N; Iida S; Maemura T; Kuroda M; Sato Y; Ito M; Okuda M; Yamada S; Iwatsuki-Horimoto K; Watanabe T; Imai M; Armbrust T; Baric RS; Halfmann PJ; Suzuki T; Kawaoka Y
    mBio; 2021 Feb; 13(1):e0304421. PubMed ID: 35100870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 Omicron variant causes mild pathology in the upper and lower respiratory tract of hamsters.
    Armando F; Beythien G; Kaiser FK; Allnoch L; Heydemann L; Rosiak M; Becker S; Gonzalez-Hernandez M; Lamers MM; Haagmans BL; Guilfoyle K; van Amerongen G; Ciurkiewicz M; Osterhaus ADME; Baumgärtner W
    Nat Commun; 2022 Jun; 13(1):3519. PubMed ID: 35725735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of Adaptive Immunity Enhances Disease in SARS-CoV-2-Infected Syrian Hamsters.
    Brocato RL; Principe LM; Kim RK; Zeng X; Williams JA; Liu Y; Li R; Smith JM; Golden JW; Gangemi D; Youssef S; Wang Z; Glanville J; Hooper JW
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32900822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross protection to SARS-CoV-2 variants in hamsters with naturally-acquired immunity.
    Beitari S; Duque D; Bavananthasivam J; Hewitt M; Sandhu JK; Hadžisejdić I; Tran A
    Virol J; 2023 Jul; 20(1):167. PubMed ID: 37507719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.